Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

Examining scalp tissue under a microscope helps diagnose and understand hair loss diseases.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Pix Liquida may help treat alopecia areata.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Lymecycline may help with Frontal Fibrosing Alopecia but needs more research.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.